Cargando…

Novel vaccines for allergen-specific immunotherapy

Allergen-specific immunotherapy (AIT) is a highly economic, effective and disease-modifying form of allergy treatment but requires accurate prescription and monitoring. New molecular approaches are currently under development to improve AIT by reducing treatment-related side effects, cumbersome prot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Akinfenwa, Oluwatoyin, Rodríguez-Domínguez, Azahara, Vrtala, Susanne, Valenta, Rudolf, Campana, Raffaela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Special Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810419/ https://www.ncbi.nlm.nih.gov/pubmed/33369572 http://dx.doi.org/10.1097/ACI.0000000000000706

Ejemplares similares

Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel mechanisms of action for the future
por: Valenta, Rudolf, et al.
Publicado: (2016)

Recombinant allergens for immunotherapy: state of the art
por: Zhernov, Yury, et al.
Publicado: (2019)

Next-Generation of Allergen-Specific Immunotherapies: Molecular Approaches
por: Curin, Mirela, et al.
Publicado: (2018)

Preventive Administration of Non-Allergenic Bet v 1 Peptides Reduces Allergic Sensitization to Major Birch Pollen Allergen, Bet v 1
por: Akinfenwa, Oluwatoyin, et al.
Publicado: (2021)

The Molecular Allergen Recognition Profile in China as Basis for Allergen-Specific Immunotherapy
por: D’souza, Nishelle, et al.
Publicado: (2021)

Recombinant allergy vaccines based on allergen-derived B cell epitopes
por: Valenta, Rudolf, et al.
Publicado: (2017)

Allergen Peptides, Recombinant Allergens and Hypoallergens for Allergen-Specific Immunotherapy
por: Marth, Katharina, et al.
Publicado: (2014)

Preventive Allergen-Specific Vaccination Against Allergy: Mission Possible?
por: Tulaeva, Inna, et al.
Publicado: (2020)

Allergen-specific IgE levels and the ability of IgE-allergen complexes to cross-link determine the extent of CD23-mediated T-cell activation
por: Villazala-Merino, Sergio, et al.
Publicado: (2019)

Allergic sensitization to Mal d 1 without detectable specific serum IgE
por: Litovkina, Alla, et al.
Publicado: (2022)

Different IgE recognition of mite allergen components in asthmatic and nonasthmatic children
por: Resch, Yvonne, et al.
Publicado: (2015)

Microarray-Based Allergy Diagnosis: Quo Vadis?
por: Huang, Huey-Jy, et al.
Publicado: (2021)

Non-IgE-reactive allergen peptides deteriorate the skin barrier in house dust mite-sensitized atopic dermatitis patients
por: Pfisterer, Karin, et al.
Publicado: (2023)

Monitoring Allergen Immunotherapy Effects by Microarray
por: Lupinek, Christian, et al.
Publicado: (2016)

Isolation, characterization and expression in Escherichia coli of a cDNA coding for a novel major wheat food allergen
por: Schmidhuber, Alexandra, et al.
Publicado: (2011)

Characterization of a new wheat food allergen
por: Pahr, Sandra, et al.
Publicado: (2011)

Epicutaneous allergen application preferentially boosts specific T cell responses in sensitized patients
por: Campana, Raffaela, et al.
Publicado: (2017)

Molecular, Structural and Immunological Characterization of Der p 18, a Chitinase-Like House Dust Mite Allergen
por: Resch, Yvonne, et al.
Publicado: (2016)

Past, present, and future of allergen immunotherapy vaccines
por: Dorofeeva, Yulia, et al.
Publicado: (2020)

A hypoallergenic peptide mix containing T cell epitopes of the clinically relevant house dust mite allergens
por: Huang, Huey‐Jy, et al.
Publicado: (2019)

Induction of allergen-specific blocking IgG using patch delivered recombinant Bet v 1 in guinea pigs
por: Cabauatan, Clarissa, et al.
Publicado: (2014)

Safety of allergen‐specific immunotherapy in children
por: De Filippo, Maria, et al.
Publicado: (2022)

AIT (allergen immunotherapy): a model for the “precision medicine”
por: Passalacqua, Giovanni, et al.
Publicado: (2015)

Reduction in allergen-specific IgE binding as measured by microarray: A possible surrogate marker for effects of specific immunotherapy
por: Wollmann, Eva, et al.
Publicado: (2015)

Prophylactic and therapeutic vaccination with carrier-bound Bet v 1 peptides lacking allergen-specific T cell epitopes reduces Bet v 1-specific T cell responses via blocking antibodies in a murine model for birch pollen allergy
por: Linhart, B, et al.
Publicado: (2014)

Personalized medicine and allergen immunotherapy: the beginning of a new era?
por: Incorvaia, Cristoforo, et al.
Publicado: (2021)

Allergen-specific immunotherapy
por: Moote, William, et al.
Publicado: (2011)

Allergen-specific immunotherapy
por: Moote, William, et al.
Publicado: (2018)

Allergen-Specific Antibodies Regulate Secondary Allergen-Specific Immune Responses
por: Eckl-Dorna, Julia, et al.
Publicado: (2019)

Determination of IgE and IgG reactivity to more than 170 allergen molecules in paper-dried blood spots
por: Garib, Victoria, et al.
Publicado: (2018)

One more step towards a deeper understanding of the mechanisms of allergen immunotherapy
por: Incorvaia, Cristoforo
Publicado: (2018)

Microarrayed dog, cat, and horse allergens show weak correlation between allergen-specific IgE and IgG responses(⋆)()
por: Curin, Mirela, et al.
Publicado: (2014)

Effects of Nasal Corticosteroids on Boosts of Systemic Allergen-Specific IgE Production Induced by Nasal Allergen Exposure
por: Egger, Cornelia, et al.
Publicado: (2015)

Mechanisms of allergen-specific immunotherapy
por: Fujita, Hiroyuki, et al.
Publicado: (2012)

Allergen-Specific Immunotherapy in Asthma
por: Jutel, Marek
Publicado: (2014)

Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens
por: Akdis, Cezmi A, et al.
Publicado: (2015)

Poor association of allergen‐specific antibody, T‐ and B‐cell responses revealed with recombinant allergens and a CFSE dilution‐based assay
por: Eckl‐Dorna, J., et al.
Publicado: (2015)

Allergen Extracts for In Vivo Diagnosis and Treatment of Allergy: Is There a Future?
por: Valenta, Rudolf, et al.
Publicado: (2018)

Vaccination of nonallergic individuals with recombinant hypoallergenic fragments of birch pollen allergen Bet v 1: Safety, effects, and mechanisms
por: Campana, Raffaela, et al.
Publicado: (2018)

Allergen-Specific Immunotherapy in Food Anaphylaxis
por: Kerzl, Regina, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_en30qetfms7bqb34u718kkqhgs